Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
65.84
-1.64 (-2.43%)
Jan 13, 2026, 4:00 PM EST - Market closed
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $4.37 billion as of January 13, 2026. Its market cap has decreased by -31.22% in one year.
Market Cap
4.37B
Enterprise Value
4.60B
1-Year Change
-31.22%
Ranking
Category
Stock Price
$65.84
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $4.37B, an increase of 2,340.45%. That is a compound annual growth rate of 35.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 4.47B | 1.40% |
| Dec 31, 2025 | 4.41B | -29.05% |
| Dec 31, 2024 | 6.22B | 46.48% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
| Jun 25, 2015 | 178.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |